Newsletter | July 17, 2026

07.17.26 -- Cell Therapy Without The Cells: Building A Therapeutic Secretome With Noveome Biotherapeutics' Larry Brown, Sc.D.

FOCUS ON SUPPLY CHAIN

Stabilizing Your Supply Chain In Times Of Global Volatility

Discover how a proactive, risk-based supply chain strategy can help strengthen resilience, mitigate disruption, and ensure continuity across your biotech and pharmaceutical operations.

A Comparative Analysis Between Liquid Nitrogen And Mechanical Freezers

Explore the differences between liquid nitrogen and mechanical cryogenic freezers, and learn how each method supports scientific, medical, and industrial storage needs.

FOCUS ON PROCESS ENGINEERING

Cell Therapy Without The Cells: Building A Therapeutic Secretome With Noveome Biotherapeutics' Larry Brown, Sc.D.

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Larry Brown, Sc.D., chief scientific officer at Noveome Biotherapeutics, to discuss ST266, a first-of-its-kind secretome therapy.

Pathogen Detection And Characterization

Unlock high-quality transcriptome data from degraded or low-input samples with a 6.5-hour workflow and enhanced sensitivity for rare transcripts and viral detection, even from FFPE tissues.

Optimizing Bispecific Antibody Expression Via Multi-Omics Analysis

Read about how diagnosing ribosome pausing sites and optimizing codon usage dramatically improves bispecific antibody titers, turning difficult-to-express candidates into viable therapeutics.

An Expert's Guide To Scaling And Intensifying Bioprocesses

Gain insights that can support your next steps, whether advancing to a new clinical phase, constructing a new facility, or fine-tuning an existing process to keep pace with market shifts.

Organ-Chips For Drug Development

Delve into how Organ-on-Chip technology significantly enhances drug development processes and improves the accuracy of clinical translation, leading to more effective and reliable therapeutic outcomes.

Accelerating The CMC Development Of Multi-Specific Biologics

Integrated analytics address multispecific antibody CMC challenges, accelerating timelines, reducing risk, and improving decisions through mechanism-driven bioassays, automation, and real-world case studies.

Streamlining Process Characterization Toward Successful Validation

Compress your biologics process characterization timeline without sacrificing quality. Learn how FMEA, DoE, and platform approaches help you hit PPQ readiness faster while managing regulatory risk.

CMC (Chemistry, Manufacturing And Controls) Management

Eliminate regulatory risks caused by fragmented data. Find out how a continuous data thread from bench to batch streamlines tech transfer and accelerates filing timelines.

Decoding Asymmetric Cell Division Via Single-Molecule Imaging

Cell polarity, the asymmetric organization of eukaryotic cells, is vital for tissue development and homeostasis, but intracellular assembly of the protein complexes involved remains unclear.

Future-Proof Your Bioprocess: The Science And Supply Chain

High-purity trypsin and carboxypeptidase B enable critical protein processing in manufacturing. See how animal-free, GMP-grade production meets quality standards for growing operations.

PAT Monitoring And Control Roadmap

Uncover how to implement PAT effectively with a roadmap that covers techniques, validation, data integrity, and lifecycle strategies to help teams improve quality, control, and productivity.

Lyophilization: Protecting And Preserving Biologics

Examine how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

PROCESS ENGINEERING SOLUTIONS

Blast Freezing And Thawing For Any Primary Packaging - Single Use Support

Faster And Safer CMC Development - ValGenesis

Powering Production Of Viral Vector-Based Therapies - Cytiva

Enzyme Indicator Technology - Protak Scientific Ltd

Sanitary Fittings For Fluid Transport - Nordson MEDICAL

Connect With Bioprocess Online: